These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 8801065)
1. Identification of the human hepatic cytochromes P450 involved in the in vitro oxidation of antipyrine. Sharer JE; Wrighton SA Drug Metab Dispos; 1996 Apr; 24(4):487-94. PubMed ID: 8801065 [TBL] [Abstract][Full Text] [Related]
2. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation. Engel G; Hofmann U; Heidemann H; Cosme J; Eichelbaum M Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486 [TBL] [Abstract][Full Text] [Related]
3. Effects of benzyl isothiocyanate on rat and human cytochromes P450: identification of metabolites formed by P450 2B1. Goosen TC; Mills DE; Hollenberg PF J Pharmacol Exp Ther; 2001 Jan; 296(1):198-206. PubMed ID: 11123381 [TBL] [Abstract][Full Text] [Related]
4. Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes. Yamazaki H; Shaw PM; Guengerich FP; Shimada T Chem Res Toxicol; 1998 Jun; 11(6):659-65. PubMed ID: 9625734 [TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites. Avent KM; DeVoss JJ; Gillam EM Chem Res Toxicol; 2006 Jul; 19(7):914-20. PubMed ID: 16841959 [TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro. Spracklin DK; Hankins DC; Fisher JM; Thummel KE; Kharasch ED J Pharmacol Exp Ther; 1997 Apr; 281(1):400-11. PubMed ID: 9103523 [TBL] [Abstract][Full Text] [Related]
7. Involvement of multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes in the in vitro metabolism of muraglitazar. Zhang D; Wang L; Chandrasena G; Ma L; Zhu M; Zhang H; Davis CD; Humphreys WG Drug Metab Dispos; 2007 Jan; 35(1):139-49. PubMed ID: 17062778 [TBL] [Abstract][Full Text] [Related]
8. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450. Zhao XJ; Yokoyama H; Chiba K; Wanwimolruk S; Ishizaki T J Pharmacol Exp Ther; 1996 Dec; 279(3):1327-34. PubMed ID: 8968357 [TBL] [Abstract][Full Text] [Related]
9. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes. Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808 [TBL] [Abstract][Full Text] [Related]
10. Formation of a dihydroxy metabolite of phenytoin in human liver microsomes/cytosol: roles of cytochromes P450 2C9, 2C19, and 3A4. Komatsu T; Yamazaki H; Asahi S; Gillam EM; Guengerich FP; Nakajima M; Yokoi T Drug Metab Dispos; 2000 Nov; 28(11):1361-8. PubMed ID: 11038165 [TBL] [Abstract][Full Text] [Related]
11. Metabolic activation of the potent carcinogen dibenzo[a,h]anthracene by cDNA-expressed human cytochromes P450. Shou M; Krausz KW; Gonzalez FJ; Gelboin HV Arch Biochem Biophys; 1996 Apr; 328(1):201-7. PubMed ID: 8638931 [TBL] [Abstract][Full Text] [Related]
12. Identification of the human liver microsomal cytochrome P450s involved in the metabolism of N-nitrosodi-n-propylamine. Teiber JF; Hollenberg PF Carcinogenesis; 2000 Aug; 21(8):1559-66. PubMed ID: 10910959 [TBL] [Abstract][Full Text] [Related]
13. Microsomal ethanol oxidizing system activity by human hepatic cytochrome P450s. Asai H; Imaoka S; Kuroki T; Monna T; Funae Y J Pharmacol Exp Ther; 1996 May; 277(2):1004-9. PubMed ID: 8627510 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the selectivity of In vitro probes and suitability of organic solvents for the measurement of human cytochrome P450 monooxygenase activities. Hickman D; Wang JP; Wang Y; Unadkat JD Drug Metab Dispos; 1998 Mar; 26(3):207-15. PubMed ID: 9492382 [TBL] [Abstract][Full Text] [Related]
15. Human cytochrome p450 enzyme specificity for the bioactivation of estragole and related alkenylbenzenes. Jeurissen SM; Punt A; Boersma MG; Bogaards JJ; Fiamegos YC; Schilter B; van Bladeren PJ; Cnubben NH; Rietjens IM Chem Res Toxicol; 2007 May; 20(5):798-806. PubMed ID: 17407329 [TBL] [Abstract][Full Text] [Related]
16. Specificity of cDNA-expressed human and rodent cytochrome P450s in the oxidative metabolism of the potent carcinogen 7,12-dimethylbenz[a]anthracene. Shou M; Korzekwa KR; Krausz KW; Buters JT; Grogan J; Goldfarb I; Hardwick JP; Gonzalez FJ; Gelboin HV Mol Carcinog; 1996 Dec; 17(4):241-9. PubMed ID: 8989918 [TBL] [Abstract][Full Text] [Related]
17. Metabolism of 5-methylchrysene and 6-methylchrysene by human hepatic and pulmonary cytochrome P450 enzymes. Koehl W; Amin S; Staretz ME; Ueng YF; Yamazaki H; Tateishi T; Guengerich FP; Hecht SS Cancer Res; 1996 Jan; 56(2):316-24. PubMed ID: 8542586 [TBL] [Abstract][Full Text] [Related]
18. Roles of human hepatic cytochrome P450s 2C9 and 3A4 in the metabolic activation of diclofenac. Tang W; Stearns RA; Wang RW; Chiu SH; Baillie TA Chem Res Toxicol; 1999 Feb; 12(2):192-9. PubMed ID: 10027798 [TBL] [Abstract][Full Text] [Related]
19. The involvement of cytochrome P450 3A4 in the N-demethylation of L-alpha-acetylmethadol (LAAM), norLAAM, and methadone. Moody DE; Alburges ME; Parker RJ; Collins JM; Strong JM Drug Metab Dispos; 1997 Dec; 25(12):1347-53. PubMed ID: 9394023 [TBL] [Abstract][Full Text] [Related]
20. Diazinon, chlorpyrifos and parathion are metabolised by multiple cytochromes P450 in human liver. Mutch E; Williams FM Toxicology; 2006 Jul; 224(1-2):22-32. PubMed ID: 16757081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]